Digitisation | August 24, 2022
3Brain AG's Accura-3D microchip, enters the market
3D CMOS chip for connecting electroactive tissues and organoids to software
3D CMOS chip for connecting electroactive tissues and organoids to software
The company continues to cooperate with the US FDA and is committed to undertake all necessary steps required to address their observations at the earliest
Carbamazepine Tablets are indicated for use as an anticonvulsant drug and in the treatment of the pain associated with true trigeminal neuralgia
The approved product has an estimated market size of around US $62 million for the twelve months ending June 2022 according to IQVIA
This rapid analytical technique provides additional information about the polymorph and solid-state properties of active pharmaceutical ingredients (APIs)
The drug is expected to cater to the fast growing Rheumatoid Arthritis, Plaque Psoriasis, JIA, Psoriatic Arthritis, Ankylosing Spondylitis, Ulcerative Colitis, Crohns disease, HS and Uveitis markets
The integrated services ensure that NextPoint can bring their molecule to the clinic in a timely manner.
Collaboration supports multiple discovery efforts, including vaccines
The estimated capex is to the tune of Rs. 140 crore to be funded through debt and internal accrual
The approved product has an estimated market size of around US$ 606 million for the twelve months ending June 2022, according to IQVIA.
Subscribe To Our Newsletter & Stay Updated
